Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
Thermo Fisher Scientific Inc. (TMO) had Cash Flow from Financial Activities of $-1.09B for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$10.86B |
|
$1.62B |
|
$6.38B |
|
$4.48B |
|
$9.02B |
|
$1.83B |
|
$-126.00M |
|
$1.71B |
|
$1.71B |
|
$1.62B |
|
$1.62B |
|
$1.62B |
|
$1.62B |
|
$1.83B |
|
-- |
|
378.00M |
|
378.00M |
|
$4.28 |
|
$4.28 |
|
| Balance Sheet Financials | |
$24.58B |
|
$9.63B |
|
$76.65B |
|
$101.23B |
|
$12.72B |
|
$33.02B |
|
$38.03B |
|
$50.75B |
|
-- |
|
$-11.92B |
|
$50.48B |
|
-- |
|
| Cash Flow Statement Financials | |
$2.12B |
|
$-815.00M |
|
|
Cash Flow from Financial Activities |
$-1.09B |
$4.04B |
|
$4.60B |
|
$563.00M |
|
-- |
|
$-311.00M |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|